Today: 19 March 2026
Subscribe
Browse Category

ASX:COL.AX 26 January 2026 - 5 March 2026

Coles share price today: COL.AX slips but beats ASX tumble as dividend date nears

Coles share price today: COL.AX slips but beats ASX tumble as dividend date nears

Coles Group shares closed down 0.5% at A$21.25, outperforming the S&P/ASX 200’s 1.94% drop to 8,901.20. Australia’s economy grew 0.8% in the December quarter, while oil prices surged over 10% after Middle East disruptions, raising rate hike bets for May. Coles’ interim dividend of 41.0 cents goes ex-dividend March 10. Woolworths fell 0.96% to A$35.94.
4 March 2026
···
Coles share price drops 7% after half-year profit slips — what ASX:COL investors watch next

Coles share price drops 7% after half-year profit slips — what ASX:COL investors watch next

Coles Group shares fell 7.3% to A$20.56 after reporting a half-year net profit drop of 11.3% to A$511 million, hit by A$235 million in legal costs. Underlying profit rose 12.5% to A$676 million. The board declared a 41-cent fully franked interim dividend, payable March 30. Coles flagged ongoing competition and legal risks, including an ACCC lawsuit over promotions.
27 February 2026
··
Coles share price slips as earnings loom and ACCC “Down Down” court fight hangs over stock

Coles share price slips as earnings loom and ACCC “Down Down” court fight hangs over stock

Coles Group shares fell 0.2% to A$21.82 on Wednesday as the ACCC pressed its case alleging Coles misled shoppers with some “Down Down” promotions. Justice Michael O’Bryan questioned the regulator’s framing; the trial resumes Thursday. Coles reports interim results Friday, with analysts expecting sales near A$23.77 billion and underlying NPAT of A$680–700 million.
25 February 2026
···

Stock Market Today

  • GBT.PA Guerbet SA surges 10% intraday on EURONEXT; mixed technical and fundamental signals
    March 19, 2026, 10:45 AM EDT. GBT.PA stock of Guerbet SA jumped 10% intraday on March 19, 2026, reaching €9.24 on EURONEXT, backed by increased volume of 13,540 shares. The rise contrasts with a challenging fundamental backdrop including a negative earnings per share of -8.93 and a debt-to-equity ratio above 1. Meyka AI assigned a HOLD rating with a price target of €18.13, suggesting near 96% upside. Technical indicators signal oversold conditions but face resistance at the 50-day (€13.27) and 200-day (€16.76) averages. Risks include deep value from price-to-book 0.31 and interest coverage issues. Analysts recommend cautious positions with tight stops, eyeing upcoming earnings and sector dynamics in European Healthcare device stocks.
Go toTop